TRIM31 and neoplasm: To determine TRIM31 expression in various cancers, preliminary screening was conducted via TIMER20 (Tumor Immune Estimation Resource, http://timer.cistrome.org/) and GEPIA221 (Gene Expression Profiling Interactive Analysis, http://gepia2.cancer-pku.cn/) online tools.